Copyright
©2010 Baishideng.
World J Gastroenterol. May 7, 2010; 16(17): 2120-2128
Published online May 7, 2010. doi: 10.3748/wjg.v16.i17.2120
Published online May 7, 2010. doi: 10.3748/wjg.v16.i17.2120
Table 1 Effect of washing on labeling rate (n = 6)
Number of washes | Labeling rate (%) |
0 | 68.01 ± 2.09 |
1 | 47.74 ± 2.26 |
2 | 43.68 ± 2.19 |
3 | 42.72 ± 2.23 |
4 | 42.22 ± 2.27 |
5 | 41.91 ± 2.28 |
6 | 41.56 ± 2.27 |
7 | 41.00 ± 2.29 |
Table 2 Ratio of radioactivity between the liver and thyroid (n = 6) after the administration of 131I-labeled gelatin microspheres
Time | Liver/thyroid |
4 h | 15.910 ± 0.740 |
Day 4 | 27.197 ± 5.467 |
Day 8 | 81.467 ± 24.637 |
Day 16 | 91.670 ± 23.278 |
Day 24 | 93.601 ± 21.337 |
Day 32 | 112.608 ± 12.787 |
Day 48 | 162.875 ± 7.955 |
Table 3 Effects of the administration of 131I-labeled gelatin microspheres on hepatic function (n = 4)
ALT (IU/L) | AST (IU/L) | ALP (IU/L) | GGT (IU/L) | TP (g/L) | ALB (g/L) | GLB (g/L) | |
Before administration | 67.75 ± 11.87 | 55.00 ± 11.87 | 99.75 ± 14.99 | 6.00 ± 1.83 | 54.33 ± 3.16 | 46.05 ± 2.32 | 8.28 ± 2.79 |
After administration | |||||||
1 d | 291.50 ± 12.79 | 146.00 ± 13.88 | 115.00 ± 25.92 | 9.25 ± 3.30 | 60.23 ± 1.96 | 45.65 ± 5.17 | 15.00 ± 5.34 |
4 d | 46.75 ± 4.79 | 41.25 ± 10.69 | 91.00 ± 29.59 | 7.25 ± 1.26 | 58.43 ± 8.45 | 47.55 ± 3.53 | 12.23 ± 5.03 |
8 d | 48.50 ± 14.39 | 48.00 ± 17.32 | 79.75 ± 14.77 | 7.50 ± 0.58 | 58.10 ± 4.40 | 44.63 ± 2.33 | 13.65 ± 4.33 |
16 d | 37.25 ± 9.32 | 39.75 ± 11.81 | 76.00 ± 9.83 | 9.50 ± 3.11 | 62.13 ± 5.84 | 44.38 ± 7.41 | 19.85 ± 6.79 |
24 d | 46.50 ± 16.01 | 45.25 ± 9.95 | 96.25 ± 17.08 | 8.00 ± 2.83 | 60.28 ± 4.45 | 47.60 ± 7.38 | 14.50 ± 3.54 |
32 d | 52.25 ± 14.29 | 46.25 ± 8.66 | 96.75 ± 35.58 | 12.50 ± 3.87 | 63.55 ± 4.90 | 46.40 ± 4.06 | 18.63 ± 6.72 |
48 d | 43.75 ± 10.01 | 40.25 ± 14.45 | 97.25 ± 7.93 | 9.25 ± 1.71 | 60.78 ± 4.08 | 46.83 ± 4.06 | 14.23 ± 4.22 |
64 d | 45.50 ± 4.80 | 45.75 ± 3.24 | 91.75 ± 29.62 | 10.50 ± 3.42 | 61.92 ± 8.18 | 50.15 ± 5.30 | 15.05 ± 3.89 |
Table 4 Effects of the administration of 131I-labeled gelatin microspheres on thyroid function (n = 4)
FT3 (pmol/L) | FT4 (pmol/L) | TSH (mU/L) | |
Before administration | 5.55 ± 0.57 | 19.61 ± 1.54 | < 0.005 |
After administration | |||
1 d | 4.54 ± 1.53 | 19.31 ± 6.47 | < 0.005 |
4 d | 5.09 ± 1.68 | 21.31 ± 4.68 | < 0.005 |
8 d | 3.29 ± 0.83 | 14.23 ± 2.81 | < 0.005 |
16 d | 5.53 ± 1.01 | 19.95 ± 2.56 | < 0.005 |
24 d | 5.31 ± 0.57 | 20.39 ± 2.38 | < 0.005 |
32 d | 4.66 ± 2.17 | 19.18 ± 2.98 | < 0.005 |
48 d | 6.02 ± 2.77 | 20.94 ± 10.78 | < 0.005 |
64 d | 5.34 ± 1.34 | 21.23 ± 3.42 | < 0.005 |
-
Citation: Ma Y, Wan Y, Luo DH, Duan LG, Li L, Xia CQ, Chen XL. Direct
in vivo injection of 131I-GMS and its distribution and excretion in rabbit. World J Gastroenterol 2010; 16(17): 2120-2128 - URL: https://www.wjgnet.com/1007-9327/full/v16/i17/2120.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i17.2120